.

Report: Parent Company Shakes Up Leadership At Gaithersburg Biotech Giant

MedImmune executive Bahija Jallal will replace current MedImmune President Peter Greenleaf, Washington Business Journal reports.

Gaithersburg biotech giant MedImmune is under new leadership thanks to a shakeup by its parent company, AstraZeneca, according to a report by Washington Business Journal.

MedImmune executive Bahija Jallal will replace current MedImmune President Peter Greenleaf as chief of the Gaithersburg drugmaker, according to the report. Greenleaf — MedImmune's president since 2010 — will lead AstraZeneca's Latin American business beginning in March.

More changes for the biotech firm are in the works, but there has been "no announcement yet on other job changes or potential layoffs," according to the report.

Read the full story on Washington Business Journal.

Boards

More »
Got a question? Something on your mind? Talk to your community, directly.
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors.What's on your mind?What's on your mind?Make an announcement, speak your mind, or sell somethingPost something
See more »